Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0022 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0394 | 0.8965 | 0.8965 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Schistosoma mansoni | serine-rich repeat protein | 0.0093 | 0.1692 | 0.4692 |
Schistosoma mansoni | hypothetical protein | 0.0093 | 0.1692 | 0.4692 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0172 | 0.3606 | 1 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0394 | 0.8965 | 0.8965 |
Brugia malayi | Cache domain containing protein | 0.0079 | 0.1373 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0 | 0.5 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0179 | 0.3782 | 0.3782 |
Trichomonas vaginalis | regulator of G protein signaling 5, rgs5, putative | 0.0022 | 0 | 0.5 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0179 | 0.3782 | 0.3782 |
Echinococcus multilocularis | expressed protein | 0.0437 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.1373 | 1 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0087 | 0.1549 | 0.4297 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | 0 mg kg-1 | Compound was evaluated for the metrazole seizure test in mice after - 0.5 hr; data not available | ChEMBL. | 2061925 |
ED50 (functional) | 0 mg kg-1 | Compound was evaluated for the metrazole seizure test in mice after - 4 hr; ND- Not determined | ChEMBL. | 2061925 |
ED50 (functional) | 0 mg kg-1 | Compound was evaluated for the anticonvulsant activity by using minimal electroshock seizure test in mice after - 0.5 hr; ND- Not determined | ChEMBL. | 2061925 |
ED50 (functional) | 0 mg kg-1 | Compound was evaluated for the anticonvulsant activity by using minimal electroshock seizure test in mice after - 4 hr; ND- Not determined | ChEMBL. | 2061925 |
ED50 (functional) | > 300 mg kg-1 | Anticonvulsant activity was measured from scMET test by delivering the drug intraperitoneally after 0.5 hr | ChEMBL. | 2061925 |
ED50 (functional) | > 300 mg kg-1 | Anticonvulsant activity was measured from scMET test by delivering the drug intraperitoneally after 0.5 hr | ChEMBL. | 2061925 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.